# Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/repotrectinib-in-ntrk-fusion-positive-advanced-solid-tumors-a-phase-1-2-trial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Benjamin Besse,Jessica J. Lin,Lyudmila Bazhenova,Koichi Goto,A. de Langen,Dong-Wan Kim,Jürgen Wolf,Christoph Springfeld,Sanjay Popat,Wan‐Teck Lim,Misako Nagasaka,Jung Yong Hong,Christina S. Baik,Alice Hervieu,Victor Moreno,Nong Yang,Kanthi Athreya Kollengode,Haisu Yang,Yuanfang Xu,C. Calvet,Yong Yuan,A. Hammell,Alexander D. Drilon,Benjamin J. Solomon |
| Citations | 16 |
| DOI | 10.1038/s41591-025-04079-7 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41591-025-04079-7.pdf |
| OpenAlex ID | https://openalex.org/W7127579899 |
| PMID | 41639379 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Yuanfang Xu](https://scholariq.org/researchers/yuanfang-xu/)

## Paper journal

- [Nature Medicine](https://scholariq.org/journals/nature-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.